The US Food and Drug Administration (FDA) has issued warning letters to 13 Chinese medical device testing laboratories for various violations, including failure to conduct proper testing and reporting inaccurate results. The laboratories are located in Guangdong, Shanghai, and Zhejiang provinces.
